wegovy

by Linda Hudson Manager

Wegovy is a self-injectable drug that mimics the activity of the hormone GLP-1. It has the effect of lowering blood sugar levels.

Recommended Features

Semaglutide Is A GLP-1 Receptor Agonist
It Works by Mimicking a Hormone That Regulates Appetite
It Can Cause Hypoglycemia
It Affects Medicines
It Slows Stomach Emptying

Learn more about wegovy»

Review on wegovy

IN EARLY JUNE, the U.S. Food and Drug Administration (FDA) approved Wegovy for sale as a new prescription weight loss drug. This new medicine intended to chronic manage weight loss in clinically obese adults. Clinically obese is defined as a BMI of 30 or higher. Overweight individuals with a BMI of 27 are also eligible to take Wegovy as long as they suffer from a weight-related ailment.

Related to wegovy

Women’s Health: Deal with Menopausal Side Effects or PMS Side Effects

There are many products on the market today that claim to help women with their menopausal or PMS side effects. Whether the product is made to help decrease bloating, irritability, or to help make...